(BMI) Badger Meter - Overview
Stock: Meters, Valves, Sensors, Software
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.74% |
| Yield on Cost 5y | 1.45% |
| Yield CAGR 5y | 18.13% |
| Payout Consistency | 97.1% |
| Payout Ratio | 30.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.8% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -44.73 |
| Character TTM | |
|---|---|
| Beta | 0.932 |
| Beta Downside | 0.597 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.92% |
| CAGR/Max DD | 0.19 |
Description: BMI Badger Meter January 07, 2026
Badger Meter Inc. (NYSE:BMI) designs, manufactures, and markets flow-measurement and water-smart-metering solutions for municipal utilities, industrial users, and OEMs. Its product portfolio spans flow meters, valves, optical and electrochemical water-quality sensors, high-frequency pressure and leak-detection devices, and the BEACON cloud-based software suite that delivers alerts and consumer-engagement tools. Sales are executed both directly and through a network of distributors and OEM representatives, serving sectors such as water/wastewater, HVAC, and corporate sustainability.
Key recent metrics (FY 2023) include approximately $1.1 billion in revenue, a 5 % year-over-year growth rate, and an operating margin near 12 %. The company’s backlog of recurring smart-metering contracts exceeded $300 million, reflecting strong demand driven by U.S. water-infrastructure spending, which the American Water Works Association estimates will total roughly $1 trillion over the next decade. Additionally, ESG-focused capital allocation-particularly utilities’ need to meet tightening water-conservation regulations-continues to boost adoption of Badger’s advanced metering infrastructure.
For deeper quantitative analysis, you might explore ValueRay’s platform for detailed financial metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 141.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: 38.88% < 20% (prev 51.04%; Δ -12.17% < -1%) |
| CFO/TA 0.19 > 3% & CFO 183.7m > Net Income 141.6m |
| Net Debt (-226.0m) to EBITDA (221.9m): -1.02 < 3 |
| Current Ratio: 3.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.5m) vs 12m ago 0.59% < -2% |
| Gross Margin: 41.68% > 18% (prev 0.40%; Δ 4128 % > 0.5%) |
| Asset Turnover: 102.4% > 50% (prev 101.2%; Δ 1.18% > 0%) |
| Interest Coverage Ratio: -137.5 > 6 (EBITDA TTM 221.9m / Interest Expense TTM -1.36m) |
Altman Z'' 8.77
| A: 0.37 (Total Current Assets 507.1m - Total Current Liabilities 150.7m) / Total Assets 973.6m |
| B: 0.64 (Retained Earnings 624.1m / Total Assets 973.6m) |
| C: 0.21 (EBIT TTM 187.3m / Avg Total Assets 895.0m) |
| D: 2.74 (Book Value of Equity 713.3m / Total Liabilities 260.3m) |
| Altman-Z'' Score: 8.77 = AAA |
Beneish M -2.51
| DSRI: 1.20 (Receivables 112.4m/84.3m, Revenue 916.7m/826.6m) |
| GMI: 0.96 (GM 41.68% / 39.83%) |
| AQI: 1.61 (AQ_t 0.40 / AQ_t-1 0.25) |
| SGI: 1.11 (Revenue 916.7m / 826.6m) |
| TATA: -0.04 (NI 141.6m - CFO 183.7m) / TA 973.6m) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of BMI shares?
Over the past week, the price has changed by -0.82%, over one month by -13.76%, over three months by -19.50% and over the past year by -29.59%.
Is BMI a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 178 | 18.2% |
| Analysts Target Price | 178 | 18.2% |
| ValueRay Target Price | 141.6 | -5.9% |
BMI Fundamental Data Overview February 09, 2026
P/E Forward = 29.9401
P/S = 4.8619
P/B = 6.2481
P/EG = 3.1892
Revenue TTM = 916.7m USD
EBIT TTM = 187.3m USD
EBITDA TTM = 221.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -226.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.23b USD (4.46b + (null Debt) - CCE 226.0m)
Interest Coverage Ratio = -137.5 (Ebit TTM 187.3m / Interest Expense TTM -1.36m)
EV/FCF = 24.93x (Enterprise Value 4.23b / FCF TTM 169.7m)
FCF Yield = 4.01% (FCF TTM 169.7m / Enterprise Value 4.23b)
FCF Margin = 18.51% (FCF TTM 169.7m / Revenue TTM 916.7m)
Net Margin = 15.45% (Net Income TTM 141.6m / Revenue TTM 916.7m)
Gross Margin = 41.68% ((Revenue TTM 916.7m - Cost of Revenue TTM 534.6m) / Revenue TTM)
Gross Margin QoQ = 42.13% (prev 40.67%)
Tobins Q-Ratio = 4.35 (Enterprise Value 4.23b / Total Assets 973.6m)
Interest Expense / Debt = unknown (Interest Expense 205.0k / Debt none)
Taxrate = 24.79% (11.1m / 44.6m)
NOPAT = 140.9m (EBIT 187.3m * (1 - 24.79%))
Current Ratio = 3.36 (Total Current Assets 507.1m / Total Current Liabilities 150.7m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -1.02 (Net Debt -226.0m / EBITDA 221.9m)
Debt / FCF = -1.33 (Net Debt -226.0m / FCF TTM 169.7m)
Total Stockholder Equity = 683.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.83% (Net Income 141.6m / Total Assets 973.6m)
RoE = 20.71% (Net Income TTM 141.6m / Total Stockholder Equity 683.8m)
RoCE = 22.76% (EBIT 187.3m / Capital Employed (Total Assets 973.6m - Current Liab 150.7m))
RoIC = 20.90% (NOPAT 140.9m / Invested Capital 673.9m)
WACC = 9.35% (E(4.46b)/V(4.46b) * Re(9.35%) + (debt-free company))
Discount Rate = 9.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF Debug] Terminal Value 77.00% ; FCFF base≈158.7m ; Y1≈195.8m ; Y5≈333.4m
Fair Price DCF = 157.6 (EV 4.42b - Net Debt -226.0m = Equity 4.64b / Shares 29.5m; r=9.35% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 95.09 | EPS CAGR: 25.25% | SUE: -0.19 | # QB: 0
Revenue Correlation: 96.17 | Revenue CAGR: 14.60% | SUE: -1.63 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.23 | Chg30d=-0.073 | Revisions Net=-5 | Analysts=11
EPS current Year (2026-12-31): EPS=5.12 | Chg30d=-0.310 | Revisions Net=-9 | Growth EPS=+6.8% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=5.56 | Chg30d=-0.229 | Revisions Net=-4 | Growth EPS=+8.8% | Growth Revenue=+7.0%